Our study reports a unique in vivo interdependence between APP and PRP loss-of-function, detailing a biochemical interaction that considerably expands the hypothesized roles of PRP in Alzheimer Disease. Here, APP is linked to early-onset autosomal dominant Alzheimer disease.